全部分类
  • Vildagliptin (LAF-237)
Vildagliptin (LAF-237)的可视化放大

Vildagliptin (LAF-237)

A DPP-4 inhibitor

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

Vildagliptin (LAF-237)的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 10mg
    ¥650.00
    520.00
    - +
  • 25mg
    ¥0.00
    0.00
    - +
  • 50mg
    ¥1625.00
    1300.00
    - +
  • 100mg
    ¥2287.00
    1830.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajci17708
  • CAS: 274901-16-5
  • 别名: 维格列汀; LAF237; NVP-LAF 237
  • 分子式: C17H25N3O2
  • 分子量: 303.4
  • 纯度: >98%
  • 溶解度: ≥ 12.05 mg/mL in DMSO, ≥ 96.4 mg/mL in EtOH with ultrasonic, ≥ 96.8 mg/mL in Water with ultrasonic
  • 储存: Store at -20°C
  • 库存: 现货

Background

LAF-237 is a potent inhibitor of DDP-4 with IC50 value of 2.3 nM [1].
DDP-4 is an antigenic enzyme expressed on the surface of most cell types and is associated with signal transduction, apoptosis and immune regulation [1].
LAF-237 is a specific inhibitor of DDP4 and can reduce glycemia. When tested on Type II diabetes patients, LAF-237 inhibits the inactivation of GLP-1 by DPP-4, allowing GLP-1 to increase the secretion of insulin and decrease glucagon release [2].
In the glucose tolerance test with obese male Zucker rats, LAF-237 can significantly decrease glucose excursion and stimulates insulin secretion. There are 95% inhibition activities of DDP-4 two hours after the injection of LAF-237[3]. Through enhances beta cell replication and reduces apoptosis, LAF-237 increases in the number of beta cell and can sustain for 12 days after washout LAF-237. Also, LAF-237 can protect nerve fiber loss in STZ-induced diabetic adult male Sprague Dawley rats [4].
参考文献:
[1]. Chakraborty S, Rendón-Ramírez A, ásgeirsson B, et al. The dipeptidyl peptidase IV inhibitors vildagliptin and K-579 inhibit a phospholipase C: a case of promiscuous scaffolds in proteins. F1000Res, 2013, 2: 286.
[2]. Ahrén B, Landin-Olsson M, Jansson PA, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes. The Journal of Clinical Endocrinology and Metabolism, 2004, 89 (5): 2078–84.
[3] Villhauer EB, et al. 1-[[(3-hydroxy-1-adamantyl) amino] acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties. J Med Chem, 2003, 46(13), 2774-2789.
[4] Duttaroy A, et al. Combination therapy with nateglinide and vildagliptin improves postprandial metabolic derangements in Zucker fatty rats. Eur J Pharmacol, 2011, 650(2-3), 703-707.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算